• Contact
  • Login
  • Contact
  • Login
  • TTM2

  • Menu
  • Contact
  • Login
  • About the study
    • History
    • Who are we
  • News
  • Documents
  • Sites
  • Partners
  • Substudies

Covid-19 update

20 March 2020

Dear TTM2 friends,
 
We hope that all of you are well in these troubled times.
 
The Covid-19 outbreak increasingly affects the sites of the TTM2-network. Many of you are struggling to handle the difficult situation or preparing for the worst. Special thoughts to our Italian friends, we can only imagine what you are going through.
 
Thanks to you, the TTM2-trial is the largest cohort of intensive care treated CA-patients and the information obtained from our detailed follow-up is an invaluable source to develop post-arrest care for the future.
Due to the Covid-19 pandemic, we need to adapt to capture as much information as possible about the surviving patients’ health and function. At most sites, face-to-face follow must be abandoned for safety reasons. We therefore recommend a temporary switch to telephone follow-up until the situation has stabilised. Detailed instructions for the telephone follow-up are available at www.ttm2trial.org (Documents / Follow up / Telephone follow up manual). 
 
We suggest that you inform the participants that you would like to invite them to a later face-to-face follow up visit at the hospital, when the situation allows, to perform those tests that cannot be performed over the phone (some items of the MoCA, SDMT, TST, blood sampling, and some substudy tests.
If a patient is unable to participate in the telephone follow-up, try to obtain as much information as possible from a relative or proxy.
 
The 24 month follow-up time-point will be extended to 24 months + 3months to increase the number of possible face-to-face follow ups within the time-frame (follow-up at a later time-point is of course better than no follow-up).
 
We understand that it may be difficult to allocate sufficient resources to capture these important data during the crisis and we are very grateful for any data you may be able to collect. Do not hesitate to contact  gisela.lilja@med.lu.se to discuss solutions and receive support. Together we are a very strong network!
 
Warmest regards to all of you,
 
Niklas and the coordinating team

News

TTM2 Trial Results Meeting

08 June 2021

Protocol for the TTM2 follow-up published in Resuscitaiton

15 April 2020

Covid-19 update

20 March 2020

Randomisation Complete!

20 January 2020

TTM2 - Trial design article (open access).

16 November 2019

Formal Interim analysis

04 October 2019

1000!

29 May 2019

Investigator meeting in Lund 22 May

22 May 2019

Largest cardiac arrest trial in an ICU setting

22 May 2019

New FAQs

04 February 2019

Pages

  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

Helsingborg Hospital 
Anaesthesiology and Intensive Care 
Charlotte Yhlens gata 10
251 87 Helsingborg, Sweden
ttm2@ttm2trial.org

Skåne University Hospital
Center for Cardiac Arrest
Barngatan 2A, Practicum
22185 Lund, Sweden
ttm2@ttm2trial.org